Dachaigh › Ailse Endometrial › Minnesota › Minneapolis
Sgrùdaidhean clionaigeach Ailse Endometrial ann an Minneapolis, MN
Tha 18 sgrùdaidhean airson Ailse Endometrial a’ lorg phàirtichean aig làraichean ann agus timcheall air Minneapolis (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
A’ fastadhÌre 3
- Abbott-Northwestern Hospital, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mìle air falbh
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mìle air falbh
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mìle air falbh
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
A’ fastadhÌre 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mìle air falbh
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A’ fastadhÌre 3
- Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A’ fastadhÌre 3
- USOR - Minnesota Oncology/ Minneapolis Clinic, Minneapolis
- USOR - Minnesota Oncology, Minneapolis
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
A’ fastadhÌre 3
- Research Site, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
A’ fastadhÌre 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A’ fastadhÌre 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
A’ fastadhÌre 1
- Normunity Investigational Site, Minneapolis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
A’ fastadhÌre 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
A’ fastadhÌre 3
- Research Site, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
A’ fastadhÌre 2
- 518, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
A’ fastadhÌre 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Allina Health Cancer Institute, Minneapolis
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
A’ fastadhÌre 2/3
- Minnesota Oncology Hematology, P.A., Minneapolis
Sgrùdaidhean Ailse Endometrial ann am bailtean eile
- Houston, TX68 sgrùdaidhean
- New York City, NY52 sgrùdaidhean
- Boston, MA50 sgrùdaidhean
- Arlington, VA39 sgrùdaidhean
- Nashville, TN38 sgrùdaidhean
- Los Angeles, CA34 sgrùdaidhean
- St. Louis, MO29 sgrùdaidhean
- Philadelphia, PA28 sgrùdaidhean
- San Antonio, TX27 sgrùdaidhean
- Columbus, OH25 sgrùdaidhean
- Oklahoma City, OK25 sgrùdaidhean
- Chicago, IL25 sgrùdaidhean
Sgrùdaidhean eile ann an Minneapolis
- Aillse Sgamhain Neo-chealla-beag27 sgrùdaidhean
- Aillse a' bhroilleach27 sgrùdaidhean
- Cancer Ovarian24 sgrùdaidhean
- Aillse Prostata23 sgrùdaidhean
- Aillse (gach seòrsa)22 sgrùdaidhean
- Fàilligeadh a' Chridhe21 sgrùdaidhean
- Leukemia myeloid geur20 sgrùdaidhean
- Ailseachadh nan Sgamhan20 sgrùdaidhean
- Aillse colorectal19 sgrùdaidhean
- Galar Parkinson17 sgrùdaidhean
- Galarachd Cardiovasculach15 sgrùdaidhean
- Galar na h-Artaighe Coronary13 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.